Summer Leadership Series
Summer Leadership Series
UNC and Duke Present:
The Summer Leadership Series
The Summer Leadership Series (co-sponsored by UNC TIBBS, Office of Graduate Education and the Duke Office of Biomedical Graduate Education), a six-part series aimed at empowering biomedical trainees to discover and develop their own leadership potential, offers an incredible opportunity to learn more about your own strengths and weaknesses, engage in structured and meaningful professional development activities, gain a deeper understanding into what makes you “tick” as a scientist and as a future leader, and develop your confidence and competence as a professional, all while meeting other students from UNC and Duke. Participation in this program will allow you to both develop and demonstrate leadership, management, and interpersonal skills that will improve your performance as a student and as a future employee. Upon successful completion of all program requirements, you will receive a Summer Leadership Series Certificate.
Session 1 – Kickoff Event: What’s Your Leadership Style & Why Does It Matter?
Friday July 7, 9a-12p – Marsico 2004
Peter Metzner, Leadership Coaching at Dynamic Change Incorporated
Students will inventory their Emotional Intelligence (Emotional Quotient Inventory) and People Skills (PeopleMap System) to create their own personalized leadership profile and identify the strengths to cultivate and blind spots to address. Learn about how your values and assumptions shape your actions and interactions as this tailored individual feedback provides a framework to start your personal leadership journey.
Session 2 – Innovative Leadership: On the Cutting Edge
Tuesday July 11, 9a-11a – Bioinformatics 1131
Invited guests
Richard Jude Samulski, PhD, AskBio Scientific Founder
Dr. Samulski received his PhD in Medical Microbiology and Immunology from the University of Florida. His graduate work (1978-82) demonstrated the first use of AAV as a viral vector and culminated in the first US patent involving non-AAV genes inserted into AAV. After completing postdoctoral training at Princeton, he was hired to provide his expertise in AAV biology as a member of the scientific advisory board of Avigen, a new AAV research company. Later, in 1993, Dr. Samulsk co-founded an AAV-based gene therapy company called Merlin, which later merged with Somatix, Inc., which then merged in 1995 with Cell Genesys. Dr. Samulski is a former member of the Recombinant DNA Advisory Committee (RAC), a committee tasked with assisting the FDA with approving or disapproving gene therapy clinical trials in the United States. He also frequently serves as a gene therapy consultant to the FDA. Through the UNC gene therapy center, Dr. Samulski has produced within an academic setting an FDA approved AAV clinical vector used to treat children with the neurological disorder of Canavan’s disease. Dr. Samulski was Co-Founder of Bamboo Therapeutics, which was acquitted by Pfizer, and where he now serves as Vice-President, Gene Therapy. He is on extended leave from the University of North Carolina (UNC) at Chapel Hill, where he served as Professor of Pharmacology and the Director of the Gene Therapy Center, leading a team of seven Principal Investigators developing novel viral vectors and clinical gene therapy programs. Over the past three decades, his research group has pioneered the first applications of AAV as a gene transfer vector in muscle, brain and other key organs, developed self-complementary AAV vector technology, novel AAV strains and vector production technology that has paved the path for clinical gene therapy trials in Canavan’s disease, Duchenne Muscular Dystrophy, heart failure, macular degeneration, Hemophilia B, and osteoarthritis among others. He was recognized by the American Society of Gene & Cell Therapy with the Outstanding Achievement Award in 2008, has served as the past President of ASGCT, and currently serves on their Advisory Council. In addition to being the lead inventor on over 20 patents in the field of AAV vectors & gene therapy, he is a scientific founder of AGTC, Asklepios Biopharmaceutical, Inc., NanoCor Therapeutics, Chatham Therapeutics, and other entities that continue to advance the field of human gene therapy.
Gary Pace, JD, PhD — Chief Executive Officer, Cell Microsystems, Inc.
Dr. Gary Pace has over thirty years of experience in the life science field, with 20 years legal and corporate experience and 12 years in biotech research for large and small companies. He is a registered patent attorney with a record of over 40 issued US patents. Since 2001 he has helped many early and development stage companies in the life sciences with their strategic, intellectual property, and transactional activities. Dr. Pace has held executive management positions in several companies, including Novartis Corporation, Gentris Corporation, Quill Medical, Inc., and BASF Corporation. Dr. Pace has a J.D. degree from the School of Law at North Carolina Central University, and his Ph.D. from North Carolina State University.
Nick Trotta, PhD — Director, Product Applications and Market Development, Cell Microsystems, Inc.
Dr. Nick Trotta leads Cell Microsystems’ marketing and sales efforts, working with Early Adopter Program participants to identify new applications of the CellRaft™ technology. In prior positions, Dr. Trotta developed nondilutive funding pipelines and market-driven product development roadmaps for Affinergy, Inc. and Advanced Liquid Logic, Inc., the latter of which was acquired for $96M by the world’s leading DNA sequencing company, Illumina, Inc. He performed his post-doctoral training in neurobiology at Duke University, holds a Ph.D. in Biological Sciences from Vanderbilt University and bachelors’ degrees in both Biology and English from Lafayette College.
Richard E. T. Smith, PhD – Chief Operating Officer, StrideBIo, Inc.
Dr. Richard Smith is presently the Chief Operating Officer of StrideBio, Inc, a gene therapy startup based in Durham, North Carolina. Previously, he ran operations at Bamboo Therapeutics, LLC, a Chapel Hill based gene therapy startup prior to its acquisition by Pfizer in 2016. Between March 2013 and August 2014, he served as Vice President and Head of Investor Relations of bluebird bio, Inc. helping the company complete a successful initial public offering in June 2013. Previously, he served as Vice President of Investor Relations and Corporate Communications at Pharmasset, Inc. from October 2008 until January 2012, when the company was acquired by Gilead Sciences. Prior to Pharmasset, Dr Smith was a Vice President and Senior Biotechnology Analyst at JPMorgan Securities and spent nearly a decade covering US and EU biotechnology companies, working in New York, Boston and London, UK. Dr. Smith holds a Ph.D. from the University of Oxford, UK with a focus in Virology, Immunology and Molecular Biology and a M.Sc. in Toxicology from the University of Surrey.
Session 3 – Across the Spectrum: Leadership in Context – A Diversity Panel
Tuesday July 18, 9a-11a – Marsico 2004
Invited guests
Students will have a chance to query a panel of diverse leaders across academia, industry, and outreach. The panel will be followed by concurrent break-out sessions led by the panelists themselves.
Paul Godley, MD, PhD, MPP, UNC Vice Dean of Diversity & Inclusion, UNC School of Medicine
Paul A. Godley, MD, PhD, MPP, became the inaugural Vice Dean for Diversity and Inclusion in February 2017. He is a Rush S. Dickson Distinguished Professor in the Division of Hematology/Oncology at the University of North Carolina at Chapel Hill School of Medicine, Adjunct Professor in the Department of Epidemiology at the UNC Gillings School of Global Public Health, member of the UNC Lineberger Comprehensive Cancer Center, and a Senior Fellow at the UNC Sheps Center for Health Services Research. Previously Dr. Godley held the positions of Vice Dean for Finance and Administration and Executive Associate Dean for Faculty Affairs. In 2001 Dr. Godley became Director of the Program on Ethnicity, Culture, and Health Outcomes (ECHO), a university initiative to advance understanding and elimination of racial health disparities through multidisciplinary research, education and training, and community partnerships. Dr. Godley is a graduate of Yale University and Harvard Medical School, and holds a PhD in epidemiology from the UNC School of Public Health. He has also earned a master’s degree in public policy from Harvard’s John F. Kennedy School of Government. He completed his internship and residency at Case Western Reserve University Hospitals, University Hospitals of Cleveland, and the Cleveland VA Medical Canter. He came to UNC in 1987 for a research fellowship in cancer epidemiology, earning his PhD from UNC in 1993 as well as completing his subspecialty training in hematology and oncology. In addition to leading prostate cancer clinical trials he has federally funded research experience in the epidemiology of prostate cancer, determinants of treatment choice, and treatment outcomes of this common condition that disproportionately affects African-Americans. Dr. Godley is PI of the NCI-funded, “Carolina Community Networks,” which utilizes community-based participatory research to develop cancer prevention interventions.
Crystal Harden, EdD, Director of Programs and Strategic Initiatives & Chief Diversity Officer, Morehead Planetarium and Science Center
Dr. Crystal Harden oversees program initiatives for Morehead, including Morehead’s mobile labs, mobile planetarium, enrichment visits, Science in the Summer, STEMville, the North Carolina Science Festival and onsite programming. She is also leading Morehead’s diversity initiative. Prior to joining Morehead in 2008, she served as the education programs consultant for the California Department of Education. Harden holds a bachelor’s degree in chemistry from North Carolina Central University and a master’s degree in teaching from the University of North Carolina at Chapel Hill. She is also pursuing a doctorate in education at UNC-Chapel Hill. She has served as an expert on mobile programs in science education for the US Department of State in Amman, Jordan. In 2013, Harden was awarded the Outstanding Informal Educator Award from the North Carolina Science, Math and Technology Center.
Anil Goyal, PhD, CLP, VP of Business Development and Strategy, MimiVax, LLC
Dr. Anil Goyal is an entrepreneur with over 20 years of experience leading and growing biotechnology companies that are developing novel, innovative therapies, technologies and discovery platforms. He is always looking to help the next big bang in biotech world. Dr. Goyal brings experience in deal making, strategic alliances, in/out-licensing, mergers and acquisitions, and strategic planning for private and public therapeutics and diagnostics companies across multiple disease areas, especially immuno-oncology. Dr. Goval has been part of the leadership teams at 3 public and 3 private biotechnology companies that were primarily oncology focused. He is currently fractional VP of Business Development at MimiVax, LLC, (an immuno-oncology company with Phase II program for glioblastoma) and Esanex Inc., (with an oral Hsp90 inhibitor entering Phase II for lung cancer). Dr. Goyal is also the founder and managing director of consulting firm OpenDoors Group. Most recently, he served as Vice President of Business Development and a member of the management team at Heat Biologics (HTBX) immuno-oncology company. Prior to joining Heat Biologics in 2013, he served as CEO and co-founder of Qualiber, Inc., a cancer nanomedicine company launched at The University of North Carolina at Chapel Hill. Other companies during his career with business development leadership roles included: Ascletis Pharmaceuticals (Hangzhou), Optherion, Serenex (Acquired by Pfizer), Millennium Pharma (Acq. by Takeda), Osient Pharma, and Merck & Co. Dr. Goyal received his Ph.D. in Microbiology and Molecular Genetics jointly from Rutgers, The State University and University of Medicine and Dentistry of New Jersey, and is a Certified Licensing Professional (CLP™) by the Licensing Executives Society, Inc.
Ed Summers, BS, BS, Software Accessibility Specialist, SAS Institute, Inc.
Ed Summers is a blind software engineer and an accessibility specialist. He has a B.S. in Computer Science and 25 years of professional experience as a software developer and a development manager. Ed’s personal mission is to enable people with disabilities to realize their full potential in the classroom and the 21st century knowledge economy. He fulfills that mission as a leader in the software industry and disability-related not-for-profit organizations.
Ed is a Distinguished Technical Leader and Senior Manager of Accessibility at SAS, the market leader in business analytics software and services that is used at more than 80,000 sites around the world. The SAS accessibility team enables people of all abilities to access the power of analytics. Ed also serves on the Duke Eye Center Advisory Board and he is the Chair of the North Carolina State Board of Education Advisory Council for the Governor Morehead School for the Blind.
Session 4 – Mentoring, Coaching, and Leadership: The Importance of Interpersonal Skills
Tuesday July 25, 9a-11a – Marsico 6004
Kathy Lee, CEO & Founder Kintegrity Development Services LLC, and formerly Operations Learning and Talent Development Leader at Dow Chemical
This session with Kathy Lee, an industry professional with nearly three decades of industry experience and an experienced leader in talent development, will empower you to leverage your existing interpersonal skills and develop new one to use coaching and mentoring skills in any leadership position.
Session 5 – Closing Session – Leadership in Review: Evaluate Your 360-Impact
Tuesday August 1, 9a-11a – Marsico 2004
Peter Metzner, Leadership Coaching at Dynamic Change Incorporated
Sessions 1-4 will be synthesized and personal 360-Reviews for each student will be analyzed. Students will craft plans for moving forward with their personal growth based on the lessons learned thus far.
Session 6 – Leadership in Action: Challenge Yourself to Grow as a Leader
Tuesday August 8, 8a-1p – UNC’s Campus Recreation Center Challenge Course
Course Facilitators & Peer Group Leaders
Students will join small teams to accomplish five leadership activities (primarily ground-based) utilizing the high and low ropes ropes challenge course at UNC’s Campus Recreation Center.* This team-based challenge course will be combined with structured opportunities for reflection on personal goals for leadership growth.
Final Challenge – Personal Reflection and Peer Mentorship
Essay Submission and Peer-Reviewed Evaluations
The final challenge is an opportunity for participants to reflect on a defined leadership prompt in a one- to two-page anonymous response paper. Each participant will be responsible not only for crafting their own response paper, but for reading and responding to the responses of two other anonymous students. Completion of the final challenge is an excellent opportunity to synthesize and internalize the Summer Leadership Series while learning more about the motivations and goals of your peers. Completing the final challenge is required for successful completion of the Summer Leadership Series.
Required Commitment:
Students should plan to attend all six sessions. To earn the certificate of completion, participants must: a) attend Sessions 1, 5, & 6, and at least two elective sessions from Sessions 2, 3, & 4 (recommended to attend all; excused absences considered on case-by-case basis); b) submit the Personal Reflection Essay; and c) submit two peer-reviewed essay evaluations.
*Please note that any physical limitations will be accommodated, please indicate any special needs when registering to attend.